Windtree Therapeutics, a biotech firm that recently announced a $700 million BNB treasury strategy, has been delisted from Nasdaq for failing to meet a listing requirement. The BNB Inspired Rally and Subsequent Plunge Biotech company Windtree Therapeutics, which announced a massive $700 million BNB treasury move, has had its stock delisted from Nasdaq for failing […]
news.bitcoin.com
#700M #BNB #Move #Fails #Save #Windtree #Nasdaq #Delisting
$700M BNB Move Fails to Save Windtree From Nasdaq Delisting
